Epidemiology of variant CJD.

Area of Science:

• Neurology
• Epidemiology
• Pathology

Background:

• Variant Creutzfeldt-Jakob disease (vCJD) presents with distinct epidemiological patterns.
• Concerns exist regarding potential iatrogenic transmission, particularly through blood products.
• Prion protein (PrP) detection in lymphoreticular tissue suggests vCJD may be blood-borne.

Purpose of the Study:

• To summarize the current epidemiological status of vCJD.
• To assess the potential risk of vCJD transmission via blood transfusion.
• To investigate the significance of experimental TSE models for human vCJD.

Main Methods:

• Review of confirmed vCJD case data in the UK and internationally.
• Analysis of demographic data including age of onset and disease duration.
• Monitoring of regional incidence and temporal trends.
• Consideration of experimental transmissible spongiform encephalopathy (TSE) models.
• Evaluation of ongoing transfusion medicine epidemiological reviews.

Main Results:

• 100 vCJD cases in the UK, 4 internationally; mean age 28, median duration 13 months.
• Rising incidence in the UK with regional variations and a cluster in Leicestershire.
• Experimental TSE models show blood infectivity, but human relevance is unclear.
• No evidence of blood as a risk factor for sporadic CJD, but vCJD may differ.
• UK Transfusion Medicine Epidemiological Review has yielded negative results to date.

Conclusions:

• vCJD incidence is increasing, with specific demographic and geographic patterns.
• The potential for iatrogenic spread via blood transfusion remains a concern.
• Further research and surveillance are needed to clarify the risk of vCJD transmission through blood products.